These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10958028)

  • 1. What is WISDOM and why should Australia participate?
    Murkies A
    Aust Fam Physician; 2000 Aug; 29(8):796. PubMed ID: 10958028
    [No Abstract]   [Full Text] [Related]  

  • 2. WISDOM. Will Australian women participate?
    MacLennan AH; Paine BJ; Marley JE
    Aust Fam Physician; 2000 Aug; 29(8):797-801. PubMed ID: 10958029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone therapy offers no protection against heart attacks.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():404-5. PubMed ID: 12448045
    [No Abstract]   [Full Text] [Related]  

  • 5. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary artery disease in women.
    Srinivasan KN; Satyamurthy I
    J Assoc Physicians India; 2002 Feb; 50():259-64. PubMed ID: 12038659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone replacement therapy - less is often more].
    Schneider HP
    Zentralbl Gynakol; 2001 Sep; 123(9):546-7. PubMed ID: 11709750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women.
    Panjari M; Bell R; Adams J; Morrow C; Papalia MA; Astbury J; Davis SR
    J Womens Health (Larchmt); 2008 Dec; 17(10):1559-65. PubMed ID: 19000028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta-analysis finds cardioprotective effects: renaissance of hormone replacement therapy? Interview by Katharina Arnheim].
    Kuhl H
    MMW Fortschr Med; 2006 Jun; 148(26):14. PubMed ID: 16878361
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 12. Statement on results of the HERS II trial on hormone replacement therapy.
    American College of Obstetricians and Gynecologists
    Ginecol Obstet Mex; 2002 Aug; 70():406-8. PubMed ID: 12448046
    [No Abstract]   [Full Text] [Related]  

  • 13. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Tib the balance': the search for the optimal hormone replacement therapy.
    Grohé C
    Eur Heart J; 2005 Jul; 26(14):1345-6. PubMed ID: 15964858
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
    Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
    Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
    Beral V; Reeves G; Banks E
    BJOG; 2005 Jun; 112(6):692-5. PubMed ID: 15924521
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):10-2. PubMed ID: 16455008
    [No Abstract]   [Full Text] [Related]  

  • 20. Does hormonal replacement therapy actually protect against cardiovascular disease?
    Oleszczuk JJ; Wac M; Kanadys W; Keith LG
    Int J Fertil Womens Med; 2002; 47(1):38-45. PubMed ID: 11900274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.